Latest Breaking News On - Autolus ltd - Page 1 : comparemela.com

CGT Catapult appoints new Non-Executive Directors

Integration of microfluidic approaches with cell therapy manufacturing through collaboration between academia and industry

Cancer is a leading cause of death worldwide, with one in six people losing their lives to it every year. Click to read more.

Century Therapeutics Expands Board of Directors with Key Appointments

Century Therapeutics, a leading cell therapy company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today announced the appointment of Joe Jimenez as Board Chair and Cynthia Butitta as a new Independent Director.

B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Research Methods that Will Give You Proven Results | Forecast 2021-2027 | Celgene Corporation, GlaxoSmithKline plc., Novartis AG, Juno Therapeutics, Gilead Sciences. Inc., Amgen Inc., Affimed N.V, Poseida Therapeutics, Inc., and Autolus Ltd. – KSU

Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Typ